FilingSEC EDGAR8-K
Inhibikase Therapeutics Appoints Deloitte as New Independent Auditor
· SEC accepted
StageCompleted
Filing content
Inhibikase Therapeutics has dismissed CohnReznick LLP and appointed Deloitte & Touche LLP as its new independent registered public accounting firm.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…